Strategic acquisition Algorics was acquired by Precision for Medicine in March 2024, signaling a strong integration path for cross-selling biomarker-driven clinical services and potentially expanded service footprints to Precision for Medicine’s global client base.

Biomarker leadership As part of the first biomarker-driven clinical research organization, there is an opportunity to position Algorics' data services and Agile resourcing as essential capabilities for clients aiming to target patient treatments more precisely.

Global expansion Precision for Medicine has grown to 3,500 employees across 40 locations worldwide with recent openings in Japan and Singapore, presenting a pathway to scale Algorics offerings in APAC markets and leverage local partnerships.

Tech ecosystem Utilize the current tech stack—Azure, SAP SuccessFactors, Jira, Oracle-like data workflows implied by biomarker platforms, and collaboration tools—to upsell integrated tech-enabled data services, analytics, and scalable clinical operations.

Revenue & growth signals With a revenue range in the low millions and a client base served globally, there is potential to target mid-market life sciences firms seeking biomarker-driven studies, expanding presence through Precision for Medicine’s enterprise relationships and portfolio.